BASF’s Personal Care business succeeds in obtaining new cosmetic ingredient notification for Symbiocell® in China
BASF’s Personal Care business recently succeeded in obtaining a new cosmetic ingredient notification for Symbiocell®, which can be commercialized as a cosmetic ingredient with BASF’s authorization in China. A unique active ingredient, Symbiocell® (INCI: Water (and) Butylene Glycol (and) Cestrum Latifolium Leaf Extract (and) Xanthan Gum (and) Propanediol (and) Caprylyl Glycol), is proven through in vitro tests to support healthy levels of the basal expression of CD86 in skin dendritic cells. It effectively soothes sensitive skin and potentially excessive cutaneous reactions. The key component of Symbiocell®, Cestrum latifolium, is well known in tropical regions for its healing properties and has known applications for a variety of skin issues. Inspired by these properties, BASF has clinically tested a face care formulation with 2% Symbiocell® and demonstrated that it reduces the level of reactivity and discomfort in sensitive skin. The ingredient was developed in response to a growing consumer trend for cosmetic products that address common sensitive skin concerns, with Asia Pacific being the key region in focus.